Symbiotec Pharmalab Limited has informed the Exchange regarding a press release dated September 21, 2026, titled "Investor Release of Financial Results for the 1st Quarter ended June 30, 2026".
Symbiotec Pharmalab Limited has informed the Exchange regarding a press release dated September 21, 2026, titled "Investor Release of Financial Results for the 1st Quarter ended June 30, 2026".